ChemicalBook > Product Catalog >API >Urinary System Drugs >Diabetes insipidus Drugs >Desmopressin acetate

Desmopressin acetate

Desmopressin acetate Structure
CAS No.
16789-98-3
Chemical Name:
Desmopressin acetate
Synonyms
DDAVP;DDAVP ACETATE;Desmopressinum;LKT Desmopressin;Desmopressin (ADH);DESMORESSIN ACETATE;DDAVP, Desmopressin;DESMOPRESSIN ACETATE;DESMOPRESSIN MONOACETATE;DesMopressin (diacetate)
CBNumber:
CB8386483
Molecular Formula:
C48H68N14O14S2
Molecular Weight:
1129.28
MOL File:
16789-98-3.mol
MSDS File:
SDS
Modify Date:
2024/7/9 21:58:15

Desmopressin acetate Properties

Melting point 170-172°C (dec.)
storage temp. −20°C
solubility Acetic Acid (Slightly), Methanol (Slightly), Water (Slightly)
form Solid
color White to Off-White
InChIKey MLSVJHOYXJGGTR-OZEDRGHLNA-N

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H317-H332-H334
Precautionary statements  P260-P280-P314
Hazard Codes  Xn
Risk Statements  20
Safety Statements  36
WGK Germany  3
HS Code  3504009000

Desmopressin acetate Chemical Properties,Uses,Production

Uses

Antidiuretic.

General Description

Desmopressin acetate(DDAVP, Stimate) is synthetic 1-desamino-8-D-argininevasopressin. Its efficacy, ease of administration (intranasal),long duration of action, and lack of side effects make itthe drug of choice for the treatment of central diabetesinsipidus. It may also be administered intramuscularly orintravenously. It is preferred to vasopressin injectionand oral antidiuretics for use in children. It is indicatedin the management of temporary polydipsia and polyuriaassociated with trauma to, or surgery in, the pituitary region.

Clinical Use

Desmopressin, as its acetate salt, is a synthetic analogue of vasopressin in which the Nterminal Cys is devoid of its α-amino function (1-Deamino) and where Arg8 is present as its D-isomer (D-Arg8), thus the commercial acronym DDAVP. The presence of D-Arg and the absence of the N-terminal amine in the desmopressin structure have increased its half-life such that it is available for oral, parenteral, or nasal use. It is used by all three of these routes of administration to prevent or control polydipsia (excessive thirst), polyuria, and dehydration of patients with diabetes insipidus caused by a deficiency of vasopressin. It also has been approved for the treatment of nocturnal enuresis (bed-wetting), which is believed to be caused by an absence of the normal night time rise in vasopressin levels.
Desmopressin is known to cause an increase in both plasma factor VIII (antihemophilic factor) and plasminogen activator. It therefore is approved by the U.S. FDA for use, parenterally and nasally, in reducing spontaneous or trauma-induced bleeding episodes in patients with hemophilia A and type I Von Willebrand's disease, provided that their plasma factor VIII activity is greater than 5%. Stimate, the nasal spray used in treating patients with hemophilia A and type I Von Willebrand's disease, is 15-fold the concentration of DDAVP nasal spray; the latter is used in treating diabetes insipidus.

Safety

Desmopressin is generally well-tolerated in most patients. There are a few instances where patients require monitoring for adverse effects of the drug. Patients receiving desmopressin need monitoring for the occurrence of hyponatremia. Symptoms of hyponatremia include nausea, confusion, or altered mental status. As patients age, they should also be continually monitored for declining renal function, as the therapeutic index and clearance of the drug will change according to the renal function. There is no known antidote to an overdose of desmopressin. The most worrisome complication to result from an overdose is water intoxication. This condition would result in a delayed loss of consciousness and seizures in some instances. Patients require immediate admission to the intensive care unit to be monitored and have electrolyte correction.

Desmopressin acetate Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 239)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry
Euroasia Trans Continental +91 22 56349035-36 New Delhi, India 519 47 Inquiry
AURO PEPTIDES LTD +91 (40) 6672 1200 New Delhi, India 10 58 Inquiry
HEMMO PHARMACEUTICALS PVT LTD +91-22-69026200 New Delhi, India 5 58 Inquiry
A.J Chemicals 91-9810153283 New Delhi, India 6124 58 Inquiry
SynZeal Research Pvt Ltd +1 226-802-2078 Gujarat, India 6522 58 Inquiry
Indo Bioactive Labs Private Limited 08048372110Ext 827 Pune, India 1 58 Inquiry
PIRAMAL PHARMA LTD +91-22-3802 3000 New Delhi, India 28 58 Inquiry
Zibo Hangyu Biotechnology Development Co., Ltd +86-0533-2185556 +8617865335152 China 10978 58 Inquiry
Henan Bao Enluo International TradeCo.,LTD +86-17331933971 +86-17331933971 China 2503 58 Inquiry
DESMOPRESSIN MONOACETATE DESMOPRESSIN ACETATE DESMOPRESSIN ACETATE SALT DESMORESSIN ACETATE Mpr-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(S-S:1-5) 1-(3-Mercaptopropionic acid)-8-D-arginine-vasopressin diacetate 1-Deamino-8-D-arginine-vasopressin diacetate DDAVP Desmopressin (ADH) [deamino-Cys1, D-Arg8]-Vasopressin hydrate acetate salt DDAVP, Desmopressin LKT Desmopressin Mpr-Tyr-Phe-Gln-Asn-Cys-Pro-D-Arg-Gly-NH2(S-S:1-6) 1-[4-(2-amino-2-keto-ethyl)-7-(3-amino-3-keto-propyl)-10-(benzyl)-13-(4-hydroxybenzyl)-3,6,9,12,15-pentaketo-18,19-dithia-2,5,8,11,14-pentazacycloicosane-1-carbonyl]-N-[1-[(2-amino-2-keto-ethyl)carbamoyl]-4-guanidino-butyl]pyrrolidine-2-carboxamide N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[4-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-13-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-10-(phenylmethyl)-18,19-dithia-2,5,8,11,14-pentazacycloicosane-1-carbonyl]pyrrolidine-2-carboxamide N-[1-[(2-azanyl-2-oxo-ethyl)amino]-5-[bis(azanyl)methylideneamino]-1-oxo-pentan-2-yl]-1-[[4-(2-azanyl-2-oxo-ethyl)-7-(3-azanyl-3-oxo-propyl)-13-[(4-hydroxyphenyl)methyl]-3,6,9,12,15-pentaoxo-10-(phenylmethyl)-18,19-dithia-2,5,8,11,14-pentazacycloicos-1-yl]carbonyl]pyrrolidine-2-carboxamide DesMopressin (diacetate) DDAVP ACETATE [DEAMINO-CYS1,D-ARG8]-VASOPRESSIN ACETATE SALT 3-MERCAPTOPROPIONYL-TYR-PHE-GLN-ASN-CYS-PRO-D-ARG-GLY-NH2 ACETATE SALT N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[[7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(p Desmopressin Acetate(1:2) Desmopressinum DesmopressinAcetate(DDAVP) Desmopressin acetate USP/EP/BP Desmopressin(DDAVP) acetate 16789-98-3 C46H64N14O12S22C2H4O C46H64N14O12S22C2H4O2 C46H63O14N14S2 Pituitary Hormones Hormones Cytokines, Growth Factors and Hormones Cell Signaling and Neuroscience Cell Biology BioChemical Peptide hormones 16789-98-3